Details
Stereochemistry | ACHIRAL |
Molecular Formula | C17H17FN4O |
Molecular Weight | 312.3415 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1C2=C(C3=C1C(F)=CC=C3)C(=O)N(CC4=C(C)NC=N4)CC2
InChI
InChIKey=NUMKWGDDRWJQMY-UHFFFAOYSA-N
InChI=1S/C17H17FN4O/c1-10-13(20-9-19-10)8-22-7-6-14-15(17(22)23)11-4-3-5-12(18)16(11)21(14)2/h3-5,9H,6-8H2,1-2H3,(H,19,20)
Molecular Formula | C17H17FN4O |
Molecular Weight | 312.3415 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://adisinsight.springer.com/drugs/800002948
Sources: https://adisinsight.springer.com/drugs/800002948
Lurosetron (GR 87442) is a serotonin 5HT3 receptor antagonist. It was undergoing clinical evaluation with Glaxo Wellcome in the UK as a potential drug for the treatment of emesis.
Originator
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:52:32 GMT 2023
by
admin
on
Fri Dec 15 16:52:32 GMT 2023
|
Record UNII |
G694G740ZP
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C94726
Created by
admin on Fri Dec 15 16:52:32 GMT 2023 , Edited by admin on Fri Dec 15 16:52:32 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000082273
Created by
admin on Fri Dec 15 16:52:32 GMT 2023 , Edited by admin on Fri Dec 15 16:52:32 GMT 2023
|
PRIMARY | |||
|
128486-54-4
Created by
admin on Fri Dec 15 16:52:32 GMT 2023 , Edited by admin on Fri Dec 15 16:52:32 GMT 2023
|
PRIMARY | |||
|
7096
Created by
admin on Fri Dec 15 16:52:32 GMT 2023 , Edited by admin on Fri Dec 15 16:52:32 GMT 2023
|
PRIMARY | |||
|
CHEMBL2105137
Created by
admin on Fri Dec 15 16:52:32 GMT 2023 , Edited by admin on Fri Dec 15 16:52:32 GMT 2023
|
PRIMARY | |||
|
SUB08621MIG
Created by
admin on Fri Dec 15 16:52:32 GMT 2023 , Edited by admin on Fri Dec 15 16:52:32 GMT 2023
|
PRIMARY | |||
|
C83896
Created by
admin on Fri Dec 15 16:52:32 GMT 2023 , Edited by admin on Fri Dec 15 16:52:32 GMT 2023
|
PRIMARY | |||
|
LUROSETRON
Created by
admin on Fri Dec 15 16:52:32 GMT 2023 , Edited by admin on Fri Dec 15 16:52:32 GMT 2023
|
PRIMARY | |||
|
172999
Created by
admin on Fri Dec 15 16:52:32 GMT 2023 , Edited by admin on Fri Dec 15 16:52:32 GMT 2023
|
PRIMARY | |||
|
G694G740ZP
Created by
admin on Fri Dec 15 16:52:32 GMT 2023 , Edited by admin on Fri Dec 15 16:52:32 GMT 2023
|
PRIMARY | |||
|
DTXSID30155911
Created by
admin on Fri Dec 15 16:52:32 GMT 2023 , Edited by admin on Fri Dec 15 16:52:32 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
TARGET -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |